Results 91 to 100 of about 5,019,492 (194)

Oral pre-exposure prophylaxis implementation in South Africa: a case study of USAID-supported programs

Frontiers in Reproductive Health
Since the introduction of oral pre-exposure prophylaxis (PrEP) in 2016, countries have successfully scaled-up PrEP to populations at risk of HIV acquisition, including key populations, serodiscordant couples and pregnant women.
Jerome Wendoh Milimu, Lauren Parmley, Mahlodi Matjeng, Mathata Madibane, Mandisi Mabika, Jacques Livingston, Joseph Lawrence, Orapeleng Motlhaoleng, Hasina Subedar, Rethabile Tsekoa, Zandile Mthembu   +10 more
doaj   +1 more source

An exploration of multi-level factors affecting routine linkage to HIV care in Zambia’s PEPFAR-supported treatment program in the treat all era

PLOS Global Public Health
Multiple steps from HIV diagnosis to treatment initiation and confirmed engagement with the health system are required for people living with HIV to establish full linkage to care in the modern treat all era. We undertook a qualitative study to gain an in-depth understanding of the impeding and enabling factors at each step of this linkage pathway.
Jenala Chipungu, Helene Smith, Chanda Mwamba, Mwiza Haambokoma, Anjali Sharma, Theodora Savory, Maurice Musheke, Jake Pry, Carolyn Bolton, Izukanji Sikazwe, Michael E. Herce   +10 more
openaire   +4 more sources

Native American Studies Program APR Self Study

, 2014
Native American Studies Program Academic Program Review Self Study ReportNative American Studies Program Academic Program Review Self Study ReportNative American Studies ...
Native American Studies Program Academic Program Review Self Study Report, APR Self Study Report
core  

Reassessing the Socioeconomic Spillover Effects of PEPFAR: Robustness Across Alternative Difference-in-Differences Methods

Background Difference-in-differences (DID) models are a leading econometric method for estimating treatment effects associated with program interventions.
Yiqun Luan, William H. Crown
core   +1 more source

DID estimates of PEPFAR impact on all-cause mortality (ACM) rates in PEPFAR-recipient countries, 2004–2018.

DID estimates of PEPFAR impact on all-cause mortality (ACM) rates in PEPFAR-recipient countries, 2004–2018.
Gary Gaumer (10927764), Monica Jordan (17712173), William Crown (11795037), Dhwani Hariharan (17712167), Allyala Nandakumar (10751728), Jennifer Kates (17712170), Clare L. Hurley (17811114), Yiqun Luan (12905478)   +7 more
core   +1 more source

National Flood Insurance Program, substantial damage determinations

, 2006
Title from cover of PDF document (viewed Apr. 13, 2006).; "Prepared by: Christopher M. Thomas"--P. [i].; "ODNR Floodplain Management Program DOW"--from logo on cover.; "Revised 2006, Originally published 1998"--P.
Floodplain Management Program (Ohio)., Thomas, Christopher M.   +1 more
core  

CDC Global AIDS Program International Laboratory Branch : building sustainable integrated laboratory capacity in PEPFAR countries

The Global AIDS Program (GAP), through the President\u2019s Emergency Plan for AIDS Relief (PEPFAR), supports over 70 countries, bringing to bear the technical expertise gained from CDC\u2019s more than 60 year history as the premier U.S.

core  

Student Research Poster Show of the 17th Annual Acquisition Research Symposium [PDF]

, 2020
Although this year’s symposium was not held as a live event, ARP continues the annual tradition of making publicly available the posters from the students in the Aquisition Research Program.
NPS Acquisition Research Program
core  

Abstracts From AIDS 2026, the 26th International AIDS Conference, 26 – 31 July 2026 Rio de Janeiro, Brazil & virtual

Journal of the International AIDS Society, Volume 29, Issue S4, July 2026.
wiley   +1 more source

Cost-effectiveness of antiretroviral regimens used in post-exposure prophylaxis program at United States’ PEPFAR-APIN clinics in a developing country: a retrospective pharmaco-economic analysis

HIV & AIDS Review
Introduction An appropriate economic evaluation of post-exposure prophylaxis (PEP) should consider the effectiveness of different regimens prescribed for patients. Studies have not evaluated the comparative effectiveness of different PEP antiretrovirals (ARVs) based on their costs.
Abdulmuminu Isah, Nneka Uchenna Igboeli, Maxwell Ogochukwu Adibe, Chinwe Victoria Ukwe, Chibueze Anosike, Kosisochi Chinwedu Amorha   +5 more
openaire   +2 more sources